Onyx Pharmaceuticals Appoints Dr. Helen Torley as Chief Commercial Officer

by Matthew Kennedy, Benzinga Staff Writer
August 31, 2011 4:06 PM | 9 seconds read |
Onyx Pharmaceuticals, Inc. ONXX today announced that it has appointed Helen Torley, M.B. Ch. B., M.R.C.P.,  as Executive Vice President and Chief Commercial Officer.
Market News and Data brought to you by Benzinga APIs

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Comments
Posted In: NewsManagementBiotechnologyHealth Care
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!